• Prostaglandin E2 in Microenvironment Modulation and IVDD Res

  2026-06-03

  Explore how Prostaglandin E2 (PGE2) advances inflammation research and microenvironment modulation, with new insights into intervertebral disc degeneration (IVDD) and translational assay design. This article uniquely bridges mechanistic understanding with practical workflow innovation.

• Safe DNA Gel Stain: Precision, Safety, and Molecular Workflo

  2026-06-03

  Explore how Safe DNA Gel Stain advances DNA and RNA gel stain protocols by combining high sensitivity with reduced mutagenicity. This article reveals practical assay impacts and unique scientific insights not found in standard reviews.

• NADH Reductive Stress as a Biomarker in Leigh Syndrome Model

  2026-06-02

  This pilot study establishes precise quantification of NADH and NAD+ in patient-derived fibroblasts and a Leigh syndrome mouse model, revealing that elevated NADH—rather than changes in NAD+ or total NAD(H)—is associated with disease severity. The novel LC-MS/MS method outperforms traditional lactate-based assays, supporting NADH/NAD+ ratio assessment as a robust mitochondrial dysfunction biomarker.

• Carboplatin (SKU A2171): Reliable Solutions for Cancer Resea

  2026-06-02

  This article provides a scenario-driven, evidence-backed guide to optimizing cell viability and cytotoxicity assays using Carboplatin (SKU A2171). Addressing real laboratory challenges, it details protocol parameters, data interpretation, and vendor selection, ensuring reproducibility and actionable insights for biomedical researchers in preclinical oncology.

• ARCA EGFP mRNA: Direct-Detection Reporter for Mammalian Cell

  2026-06-01

  ARCA EGFP mRNA is a direct-detection reporter mRNA optimized for quantifying transfection efficiency and protein expression in mammalian cells. Featuring an Anti-Reverse Cap Analog and an optimized poly(A) tail, it enables robust, fluorescence-based assays with high reproducibility. This article details its mechanism, benchmarks, and practical integration as a standard mRNA transfection control.

• Epicardial Adipose-Neural Axis Drives Arrhythmia via Leptin-

  2026-06-01

  Fan et al. (2024) establish a stem cell-based coculture model to elucidate how the adipose-neural axis, particularly leptin and neuropeptide Y (NPY) signaling, contributes to epicardial adipose tissue-related cardiac arrhythmias. Their work identifies key molecular targets for intervention and provides mechanistic insights with implications for future research in arrhythmogenesis.

• mRNA Nanoparticle Therapy Restores BBB Post-Stroke via Micro

  2026-05-31

  The referenced study demonstrates that targeted delivery of IL-10 mRNA via mannose-functionalized lipid nanoparticles can effectively shift microglia toward a reparative M2 phenotype, restoring blood-brain barrier integrity after ischemic stroke. This approach highlights the promise of mRNA-based nanomedicine for neuroinflammatory modulation and functional recovery in post-stroke models.

• Targeted mRNA Nanoparticles Restore BBB Post-Stroke via Micr

  2026-05-30

  This study introduces a lipid nanoparticle system for targeted mRNA delivery to modulate microglia phenotypes after ischemic stroke. By promoting M2 polarization and IL-10 expression, the approach restores blood–brain barrier integrity and improves neurological outcomes, offering a significant advance for mRNA-based neurorepair strategies.

• Tacalcitol Monohydrate: Systems-Level Insights in Cancer and

  2026-05-29

  Explore how Tacalcitol monohydrate, a synthetic analog of vitamin D3, advances colorectal cancer and neuroregeneration research through unique gene modulation and synergy with chemotherapeutics. This article offers a systems-biology perspective absent from existing summaries.

• H3K18 Lactylation Drives NOD2-Mediated Pyroptosis in Astrocy

  2026-05-29

  Li et al. (2025) uncovered a glycolysis-linked epigenetic mechanism in bilirubin-induced neuroinflammation: H3K18 lactylation upregulates NOD2, promoting pyroptosis in astrocytes. This work advances understanding of metabolic-epigenetic interplay in bilirubin encephalopathy and highlights potential intervention points.

• AP20187: Unlocking Advanced Control in Conditional Gene Ther

  2026-05-28

  Discover how AP20187, a chemical inducer of dimerization, enables precise, tunable protein interaction in conditional gene therapy systems. This in-depth analysis reveals unique mechanistic insights and practical assay guidance not found in existing resources.

• HR-LCMS/MS Uncovers Glabrol as Autophagy Inducer in Astragal

  2026-05-28

  This study introduces a streamlined HR-LCMS/MS-based dereplication workflow to rapidly identify autophagy-inducing compounds in plant extracts, demonstrating its effectiveness by discovering Astragalus dasyanthus as a novel producer of glabrol. The findings offer a robust approach for high-throughput screening of bioactive plant metabolites relevant to metabolic and neurodegeneration research.

• T-5224: C-Fos/AP-1 Inhibitor for Targeted Inflammation Resea

  2026-05-27

  T-5224, a selective C-Fos/AP-1 inhibitor from APExBIO, empowers researchers to dissect neuroinflammatory and arthritic pathways with precision. Its robust inhibition of MMPs and pro-inflammatory cytokines enables translational workflows for arthritis and neuroinflammation modeling where mechanistic clarity and reproducibility are paramount.

• JZL184 (SKU B1958): Reliable MAGL Inhibition in Cell Assays

  2026-05-27

  This article provides a scenario-driven, evidence-based guide for biomedical researchers using JZL184 (SKU B1958), a potent monoacylglycerol lipase inhibitor, to address experimental challenges in endocannabinoid signaling and cell viability studies. Grounded in peer-reviewed findings, it compares vendor reliability, protocol optimization, and interpretation strategies, offering actionable insights for reproducible and sensitive assays.

• Applied Oncology Workflows with BGJ398 (NVP-BGJ398): Protoco

  2026-05-26

  Unlock selective FGFR inhibition using BGJ398 (NVP-BGJ398) to dissect FGFR-driven malignancies and developmental mechanisms. This article bridges advanced protocol parameters with troubleshooting strategies, highlighting evidence-based advantages and referencing pivotal findings for translational oncology research.

15773 records 1/1052 page Next 12345 下5页 Last page